Rating Change
Cantor Fitzgerald analysts initiated coverage on Dyne Therapeutics, Inc. (NASDAQ:DYN) with a Overweight rating on July 23, 2026.
new coverageNASDAQ:DYN
Cantor Fitzgerald Initiates Coverage on Dyne Therapeutics, Inc. (DYN) with Overweight
Rating Change Cantor Fitzgerald analysts initiated coverage on Dyne Therapeutics, Inc. (NASDAQ:DYN) with a Overweight rating on July 23, 2026. Market Context Dyne Therapeutics,…
Market Context
Dyne Therapeutics, Inc. operates in the Healthcare sector. The stock currently trades at $23.52 with a market capitalization of $2.8B.
Analyst coverage from Cantor Fitzgerald provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Dyne Therapeutics, Inc..
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for Dyne Therapeutics, Inc.
Among the 10 most recent ratings: 8 Buy, 2 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Jul 23, 2026 | Cantor Fitzgerald | Overweight | N/A |
| Jun 26, 2026 | TD Cowen | Buy | N/A |
| May 15, 2026 | Evercore ISI Group | Outperform | N/A |
| May 13, 2026 | Bernstein | Market Perform | N/A |
| Mar 09, 2026 | Chardan Capital | Buy | N/A |
Related Tools: Analyst Ratings Dashboard | View DYN Stock Page
Frequently Asked Questions
What does a Overweight rating mean for DYN?
A Overweight rating from Cantor Fitzgerald reflects the analyst's outlook on Dyne Therapeutics, Inc. (NASDAQ:DYN). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the DYN forecast page.